Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 373, Issue 3, 2006, Pages 221-229

  Shah, Dhvanit I ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

BMOV; Hypercholesterolemia; Hypertension; Protein tyrosine phosphatase; Vascular endothelial dysfunction

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ATORVASTATIN; BIS(MALTOLATO)OXOVANADIUM; DEOXYCORTICOSTERONE ACETATE; DRINKING WATER; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN TYROSINE KINASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISOLATED HEART; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; BLOOD PRESSURE; ENDOTHELINS; LIPID METABOLISM; MALE; MICROSCOPY, ELECTRON, SCANNING; NITRATES; NITRITES; PYRONES; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VANADATES; VASCULAR DISEASES; VASODILATION;

EID: 33744819731     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0066-1     Document Type: Article

References (40)

1. Brown TJ, Shuford WW, Wang WC, Nadler SG, Bailey TS, Marquardt H, Mittler RS (1996) Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells. J Biol Chem 271:27686-27695
2. Caravan P, Gelmini L, Glover N, Herring G, Li H, McNeill JH, Rettig SJ, Setyawati IA, Shuter E, Sun Y, Tracey AS, Yuen VG, Orvig C (1995) Reaction chemistry of BMOV, bis(maltolato) oxovanadium (IV) - a potent insulin mimetic. J Am Chem Soc 117:12759-12770
3. Carr AN, Davis MG, Eby-Wilken E, Howard BW, Towne BA, Dufresne TE, Peters KG (2004) Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease. Am J Physiol Heart Circ Physiol 287:H268-H276
4. David GFX, Herbert J, Wright CDS (1973) The ultrastructure of the pineal ganglion in the ferret. J Anat 115:79-97
5. De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974
6. +2-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82:686-695
7. Gao N, Ding M, Zheng JZ, Zhang A, Leonard SS, Liu KJ, Shi X, Jiang BH (2002) Vanadate-induced expression of hypoxia inducible factor 1α and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem 277:31963-31971
8. Gupta BL, Preet A, Baquer NZ (2004) Protective effects of sodium orthovanadate in diabetic reticulocytes and ageing red blood cells of Wistar rats. J Biosci 29:73-79
9. Harrington EA, Smeglin A, Newton J , Ballard G, Rounds S (2001) Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in endothelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 280:L342-L353
10. Hennig B, Toborek M, McClain CJ (2001) High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 20:97-105
11. Ignarro LJ, Bryns RE, Buga GM, Wood KS, Chaudhari G (1988) Pharmacological evidence that endothelium-derived relaxing factor is NO: use of pyrogallol and superoxide dismutase to study endothelium dependent and NO-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244:181-188
12. Kawano H, Motoyama T, Hirai N, Kugiyama K, Yasue H, Ogawa H (2002) Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress. Atherosclerosis 161:375-380
13. Knight BL, Patel DD, Humphreys SM, Wiggins D, Gibbons GF (2003) Inhibition of cholesterol absorption associated with a PPAR α-dependent increase in ABC binding cassette transporter A1 in mice. J Lipid Res 44:2049-2058
14. Kung CF, Moreau P, Takase H, Luscher TF (1994) L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Hypertension 26:744-750
15. LaVoie HA, Witorsch RJ (1995) Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells. Proc Soc Exp Biol Med 209:257-269
16. Li L, Galligan JJ, Fink GD, Chen AF (2003) Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Hypertension 41:663-668
17. Liem DA, Gho CC, Gho BC, Kazim S, Manintveld OC, Verdouw PD, Duncker DJ (2004) The tyrosine phosphatase inhibitor bis (maltolato)-oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels. J Pharmacol Exp Ther 309:1256-1262
18. Ma FA, Liu LY, Xiong XM (2003) Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacol Sin 24:1027-1032
19. Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B (2001) Statin-induced inhibition of the Rho-signaling pathway activates PPAR and induces HDL apoA-I. J Clin Invest 107:1423-1432
20. McNeill JH, Orvig C (1996) Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar. United States Patent 5527790
21. McNeill JH, Yuon VG, Dai S, Orvig C (1995) Increased potency of vanadium using organic ligands. Mol Cell Biochem 153:175-180
22. Misruski D, Tatchum-Talom R, McNeill JR, Gopalkrishnan V (2000) Vanadate evoked relaxation of the perfused rat mesenteric vascular bed. Life Sci 67:1369-1379
23. Mitra S, Singh M (1998) Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Mol Cell Biochem 183:63-67
24. Molero JC, Martinez C, Andres A, Satrustegui J, Carrascosa JM (1998) Vanadate fully stimulates insulin receptor substrate-1 associated phosphatidyl inositol 3-kinase activity in adipocytes from young and old rats. FEBS Lett 425:298-304
25. O'Rourke M, Docherty JR (1998) Effects of a high-cholesterol diet on vascular and endothelial function in rat aorta. Pharmacology 56:1-6
26. Papapetropoulos A, Fulton D, Lin MI, Fontana J, McCabe TJ, Zoellner S, Garcia-Cardena G, Zhou Z, Gratton JP, Sessa WC (2004) Vanadate is a potent activator of endothelial nitric oxide synthase: evidence for the role of serine/threonine kinase Akt and 90-kDa heat shock protein. Mol Pharmacol 65:407-415
27. Pieper GM, Langenstroer P, Siebeneich W (1997) Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 37:145-156
28. Portaluppi F, Boari B, Manfredini R (2004) Oxidative stress in essential hypertension. Curr Pharm Des 10:1695-1698
29. Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306:79-82
30. Schiller NK, Timothy AM, Chen IL, Rice RC, Akers DL, Kadowitz PJ, McNamaran DB (1999) Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. Am J Physiol 277:240-248
31. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711-1718
32. Shah DI, Singh M (2006) Inhibition of protein Tyrosine phosphatase improves vascular endothelial dysfunction. Vasc Pharmacol 44:177-182
33. Shi SJ, Preuss HG, Abernethy DR, Li X, Jarrell ST, Andrawis NS (1997) Elevated blood pressure in spontaneously hypertensive rats consuming a high sucrose diet is associated with elevated angiotensin II and is reversed by vanadium. J Hypertens 15:857-862
34. Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M (2005) Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice. J Hypertens 23:1383-1389
35. Verma S, Cam MC, McNeill JH (1998) Nutritional factors that can favorably influence the glucose/insulin system: vanadium. J Am Coll Nutr 17:11-18
36. Wang Y, Ahmad N, Kudo M, Ashraf M (2004) Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol Heart Circ Physiol 287:H1125-H1131
37. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rösen R, Böhm M, Nickenig G (2002) Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105:2083-2091
38. Wolfrum S, Jensen KS, Liao JK (2003) Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 23:729-736
39. Zhang X, Hintze TH (2001) cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels. Arterioscler Thromb Vasc Biol 21:797-803
40. Zhang AQ, Gao ZY, Gilon P, Nenquin M, Drews G, Henquin JC (1991) Vanadate stimulation of insulin release in normal mouse islets. J Biol Chem 266:21649-21656